Exploring the relationship between race and ecstasy involvement among a sample of arrestees

Journal of Ethnicity in Substance Abuse

Volumn 1, Issue 4, 2002, Pages 49-61

  Urbach, Blake J ^a   Reynolds, K Michael ^a   Yacoubian Jr , George S ^b,c  

^a UNIVERSITY OF CENTRAL FLORIDA   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c CESAR   (United States)

Author keywords

Arrest rates; Ecstasy; Race; Substance use

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE;

ADULT; ARTICLE; CONTROLLED STUDY; CRIMINAL BEHAVIOR; ETHNIC DIFFERENCE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PRISONER; RACE DIFFERENCE; SUBSTANCE ABUSE;

EID: 0038076468     PISSN: 15332640     EISSN: None     Source Type: Journal    
DOI: 10.1300/J233v01n04_03     Document Type: Article

References (41)

1. Amey, C.H.; & Albrecht, S.L. 1998. Race and ethnic differences in adolescent drug use: The impact of family structure and the quantity and quality of parental interaction. Journal of Drug Issues 28(2): 283-299.
2. Beck, J.; & Rosenbaum, M. 1994. In Pursuit of Ecstasy. New York, NY: State University of New York Press.
3. Bolla, K.I.; McCann, U.D.; & Ricaurte, G.A. 1999. Memory impairment in abstinent MDMA ("ecstasy") users. Neurology 51: 1532-1537.
4. Chilcoat, H.D.; & Schutz, C.G. 1995. Racial/ethnic and age differences in crack use within neighborhoods. Addiction Research 3(2): 103-111.
5. Dembo, R.; Williams, L.; & Schmeidler, J. 1994. Cocaine selling among urban black and white adolescent males. InternationaI Journal of the Addictions 29(14): 1813-1834.
6. Greer, G.R.: & Tolbert, R. 1998. A method of conducting therapeutic sessions with MDMA. Journal of Psychoactive Drugs 30(4): 371-379.
7. Greer, G.R.; & Tolbert, R. 1990. The therapeutic use of MDMA. In S.J. Peroutka (Ed.), Ecstasy: The Clinical, Pharmacological and Neurotoxic Effects of the Drug MDMA (pp. 21-35). Norwell, MA: Kluwar Academic Publishers.
8. Grinspoon, L. 1985. Written Testimony Submitted on Behalf of Dr Grinspoon and Greer, Professors Bakalar and Roberts (Drug Enforcement Administration Law Hearings, Docket No. 84-48). Washington, DC: U.S. Department of Justice.
9. Grinspoon, L.; & Bakalar. J.B. 1986. Can drugs be used to enhance the psychotherapeutic process? American Journal of Psychotherapy 40(3): 393-403.
10. Hayner, G.N.: & McKinney, H.E. 1986. MDMA: The dark side of ecstasy. Journal of Psychoactive Drugs 18: 341-347.
11. Henry, J.A. 1992. Ecstasy and the dance of death. British Medical Journal. 305: 5-6.
12. Henry, J.A.; Jeffreys, K.J.; & Dawling, S. 1992. Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy"). Lancet 340: 284-287.
13. Hoffman, J.H.; Welte, J.W.; & Barnes, G.M. 2001. Co-occurrence of alcohol and cigarette use among adolescents. Addictive Behaviors 26: 63-78.
14. Holsten, D.W.; & Schieser, D.W. 1986. Controls over the manufacture of MDMA. Journal of Psychoactive Drugs 18(4): 371-372.
15. Johnston, L.D.; O'Malley, P.M.; & Bachman, J.G. 2001. National Survey Results on Drug Use from the Monitoring the Future Study, 2000 (Volume I). Rockville, MD: U.S. Department of Health and Human Services.
16. Kandel, D.B.; Single, E.; & Kessler, R. 1976. The epidemiology of drug use among New York state high school students: Distribution, trends, and changes in rates of use. American Journal of Public Health 66: 43-53.
17. Karch S. 1992. "Ecstasy": The dance of death. Forensic Drug Abuse Advisor 4(7): 49-50.
18. Lawn, J.C. 1988. Schedules of controlled substances: Scheduling of 3,4-methylenedioxymethamphetamine (MDMA) into Schedule I of the Controlled Substances Act. Federal Register 51(198): 36552-36560.
19. Lawn, J.C. 1985. Schedules of controlled substances: Temporary placement of 3,4-methylenedioxymethamphetamine (MDMA) into Schedule I. Federal Register 50(105): 23118-23120.
20. Long, J.S. 1997. Regression Models for Categorical and Limited Dependent Variables. California: Sage Publications.
21. McCann, U.D.; Ridenour, A.; Shaman, Y.; & Ricaurte, G.A. 1994. Serotonin neurotoxicity after 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"): A controlled study. Neuropsychopharmacology 10(2): 129-138.
22. Morgan, M.J. 2000. Ecstasy (MDMA): A review of its possible persistent psychological effects. Psychopharmacology 152(3): 230-248.
23. Mullen, F.M. 1984. Schedules of controlled substances: Proposed placement of 3,4-methylenedioxymethamphetamine into Schedule I. Federal Register 49(146): 30210-30211.
24. Oetting, E.R.; Deffenbacher, J.L.; Taylor, M.J.; Luther, N.; Beauvais, F.; & Edwards, R.W. 2000. Methamphetamine use by high school seniors: Recent trends, gender and ethnicity differences, and use of other drugs. Journal of Child and Adolescent Substance Abuse 10(1): 33-51.
25. Parrott, A.C.; Sisk, E.; & Turner, J.J.D. 2000. Psychobiological problems in heavy "ecstasy" (MDMA) polydrug users. Drug and Alcohol Dependence 60: 105-110.
26. Peroutka, S.J. 1987. Incidence of recreational use of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') on an undergraduate campus: New England Journal of Medicine 317(24): 1542-1543.
27. Peroutka, S.J.; Newman, H.; & Harris, H. 1988. Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users. Neuropsychopharmacology 1: 273-277.
28. Randolph, W.F. 1984. International drug scheduling: Convention on psychotropic substances, stimulant and/or hallucinogenic drugs. Federal Register 49(140): 29273-29274.
29. Ricaurte, G.A.; McCann, U.D.; Szabo, Z.; & Scheffel, U. 2000. Toxicodynamics and long-term toxicity of the recreational drug, 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'). Toxicology Letters 112-113: 143-146.
30. Ricaurte, G.A.; Bryan, G.; Strauss, L.; Seiden, L.; & Schuster, C. 1985. Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals. Science 229: 986-988.
31. Seymour, R.B. 1986. MDMA. San Francisco, CA: Haight-Asbury Publications.
32. Shulgin, A. 1990. History of MDMA. In S.J. Peroutka (Ed.), Ecstasy: The Clinical, Pharmacological and Neurotoxic Effects of the Drug MDMA (pp. 1-20). Norwell, MA: Kluwar Academic Publishers.
33. Shulgin, A. 1985. What is MDMA? PharmChem Newsletter 14(3): 3-5, 10-11.
34. Shulgin, A.; & Nichols, D. 1978. Characterization of three new psychotomimetics. In R.J. Stillman and R.E. Willette (Eds.), The Psychopharmacology of Hallucinogens. New York, NY Pergamon Press.
35. Solowij, N.; Hall, W.; & Lee, N. 1992. Recreational MDMA use in Sydney: A profile of 'ecstasy' users and their experiences with the drug. British Journal of Addictions 87: 1161-1172.
36. Wallace, J.M.; & Bachman, J.G. 1991. Explaining racial/ethnic differences in adolescent drug use: The impact of background and lifestyle. Social Problems 38(3): 333-357.
37. Warheit, G.J.; & Vega, W.A. 1996. A comparative analysis of cigarette, alcohol and illicit drug use among an ethnically diverse sample of Hispanic, African-American, and non-Hispanic white adolescents. Journal of Drug Issues 26(4): 901-922.
38. Yacoubian, G. under review. Assessing the temporal relationship between race and ecstasy use among high school seniors. Journal of Drug Education.
39. Yacoubian, G. in press. Correlates of ecstasy use among 10th graders surveyed through Monitoring the Future. Journal of Psychoactive Drugs.
40. Yacoubian, G.; Arria, A.; Fost, E.; & Wish, E.D. in press. Estimating the prevalence of ecstasy use among juvenile offenders. Journal of Psychoactive Drugs.
41. Yacoubian, G.; & Urbach, B.J. under review. Exploring the temporal relationship between race and the use of ecstasy: Findings from the National Household Survey on Drug Abuse. Journal of Psychoactive Drugs.